A survey of more than 26,000 adults in 14 countries found that many people are open to adopting a pet but hold back because of what they don't know about the animal's past.
|Articles|November 4, 2010
Noted vaccine researcher joins University of Georgia faculty
Ron Mark Estes will be the Fred C. Davison Distinguished University Chair in Veterinary Medicine
Advertisement
Athens, Ga. — Veterinary immunologist and vaccine researcher Don Mark Estes is joining the faculty of the University of Georgia (UGA) College of Medicine.
Advertisement
Estes, who comes off a stint as associate director of research programs for the University of Texas' Sealy Center for Vaccine Development, will be UGA's Fred C. Davison Distinguished University Chair in Veterinary Medicine.
Estes' lab will be located in the college's infectious diseases department. The department head, Fred Quinn, says he expects Estes to improve the university's research reputation and help develop new products and technologies.
Advertisement
Related to this article
A pain management protocol is only as good as the conversation behind it.
Mindy Cannon, MBA, explains what 4CYTE is, how it is dosed, and where veterinary practices can find it, in this episode of The Vet Blast Podcast presented by dvm360
Christopher Lee, DVM, MPH, DACVPM, DACVM (Parasitology), explains Toxoplasma gondii facts, including why most indoor cats rarely shed, as well as pregnancy-safe litter tips for cat health.
The latest updates relating to animal care establishments and platforms.
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
The first survey of parasite control on bison ranches shows most herds are dewormed on a schedule, with little testing to see whether they need it. Researchers say the habit could make resistance harder to manage.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Advertisement
Advertisement
Trending on dvm360
1
A catastrophic miscarriage of justice: The truth about Toxoplasma gondii risk from household cats
2
Natural Bridge Wildlife Ranch welcomes third southern white rhino calf in 3 years
3
Bison producers deworm often but rarely test first, survey finds
4
Clinic center: Boehringer Ingelheim opens new US animal health headquarters in Georgia, Purina unveils $550 million pet food manufacturing facility in Ohio, and more
5